Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) Shares Outstanding (Weighted Average): 2023-2024

Historic Shares Outstanding (Weighted Average) for Camp4 Therapeutics (CAMP) over the last 2 years, with Dec 2024 value amounting to $20.2 million.

  • Camp4 Therapeutics' Shares Outstanding (Weighted Average) rose 58.93% to $20.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.2 million, marking a year-over-year increase of 58.93%. This contributed to the annual value of $20.2 million for FY2024, which is 58.93% up from last year.
  • As of FY2024, Camp4 Therapeutics' Shares Outstanding (Weighted Average) stood at $20.2 million, which was up 58.93% from $12.7 million recorded in FY2023.
  • Camp4 Therapeutics' Shares Outstanding (Weighted Average)'s 5-year high stood at $20.2 million during FY2024, with a 5-year trough of $12.7 million in FY2023.
  • For the 2-year period, Camp4 Therapeutics' Shares Outstanding (Weighted Average) averaged around $16.4 million, with its median value being $16.4 million (2023).
  • Data for Camp4 Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY skyrocketed of 58.93% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Camp4 Therapeutics' Shares Outstanding (Weighted Average) stood at $12.7 million in 2023, then skyrocketed by 58.93% to $20.2 million in 2024.